Table 1 Characteristics of the study participants by NAFLD status
Variables | Non-NAFLD group (n = 75) | NAFLD group (n = 72) | P- value |
|---|---|---|---|
Age (year) | 55.4 ± 9.4 | 55.8 ± 6.0 | 0.80 |
Female, n (%) | 45 (60.0%) | 38 (52.8%) | 0.38 |
BMI (kg/m2) | 27.5 (25.6–30.0) | 30.1 (27.9–33.0) | < 0.001 |
SBP (mmHg) | 120.0 (110.0-125.0) | 120.0 (110.0-130.0) | 0.11 |
DBP (mmHg) | 80.0 (80.0–80.0) | 80.0 (80.0-83.5) | 0.28 |
Fasting glucose (mg/dl) | 141.0(109.5-166.5) | 131.5(112.5-159.5) | 0.57 |
HbA1C (%) | 7.5 ± 1.3 | 7.5 ± 1.5 | 0.88 |
TG (mg/dl) | 126.0 (97.5-167.5) | 165.0 (115.5-232.5) | 0.002 |
Total chol. (mg/dl) | 141.6 ± 38.2 | 148.8 ± 37.8 | 0.26 |
LDL-chol.(mg/dl) | 70.1 ± 24.7 | 73.2 ± 23.8 | 0.59 |
HDL-chol. (mg/dl) | 51.0 (43.5–59.5) | 48.0 (40.0–54.0) | 0.01 |
ALT (IU/l) | 18.0 (13.5–23.5) | 25.0 (19.0-30.5) | < 0.001 |
AST (IU/l) | 19.0 (16.0-23.5) | 20.5(18.0–26.0) | 0.03 |
eGFR ( mL/min/1.73m2) | 72.0 ± 13.2 | 72.7 ± 4.9 | 0.76 |
Current smokers, n (%) | 7 (9.3%) | 11 (15.3%) | 0.27 |
Diabetes duration (year) | 9.0 (3.5–14.5) | 7.0 (4.5–12.0) | 0.88 |
Insulin, n (%) | 20 (26.7%) | 16 (22.2%) | 0.53 |
Anti-hypertensive, n (%) | 32 (42.7%) | 32 (44.4%) | 0.83 |
Statin, n (%) | 55 (73.3%) | 53 (73.6%) | 0.97 |
Hypertension, n (%) | 32 (42.7%) | 32 (44.4%) | 0.27 |
Dyslipidemia, n (%) | 61 (81.3%) | 69 (95.8%) | 0.006 |
CAP score (dB/m) | 266.0 (245.0-280.0) | 326.0 (316.0-340.0) | < 0.001 |
Brachial FMD ≤ 7%, n (%) | 44 (58.7%) | 56 (77.8%) | 0.013 |
Paradoxical vasoconstriction (%) | 6(8%) | 9 (12.5%) | 0.37 |